---
title: "Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296635155.md"
description: "Don Vandenbord from Revere Asset Management believes that Moderna stock may attract investors interested in AI opportunities. He suggests that the potential for AI-focused investment to enter the biotech sector is significant. This viewpoint could lead to further growth in Moderna's stock, as well as in AI-related investments in biotech."
datetime: "2026-08-21T15:14:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296635155.md)
  - [en](https://longbridge.com/en/news/296635155.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296635155.md)
generator: "portal-rs"
---

# Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech

Don Vandenbord from Revere Asset Management believes that Moderna stock may attract investors interested in AI opportunities. He suggests that the potential for AI-focused investment to enter the biotech sector is significant. This viewpoint could lead to further growth in Moderna's stock, as well as in AI-related investments in biotech.

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)

## Related News & Research

- [Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 million](https://longbridge.com/en/news/298959314.md)
- [How Cathie Wood's fund gave us a back door to Moderna's breakthrough](https://longbridge.com/en/news/298769510.md)
- [Moderna (NASDAQ:MRNA) CFO Sells $4,685,093.64 in Stock](https://longbridge.com/en/news/298963121.md)
- [Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA](https://longbridge.com/en/news/298693237.md)
- [MRNA: Phase III melanoma success fuels expansion into new cancers, with scalable manufacturing and a strong vaccine portfolio](https://longbridge.com/en/news/298941796.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**